Document Detail

Determination of plasmatic copper and zinc in uncomplicated pregnancies.
MedLine Citation:
PMID:  6723055     Owner:  NLM     Status:  MEDLINE    
The copper and zinc plasmatic concentrations were determined in a group of 50 pregnant women and in a control group. We found higher copper and lower zinc plasmatic levels in pregnancy than in control group. No correlation was found between the copper and zinc plasmatic levels and the weeks of pregnancy.
S Guaschino; P Pesando; P F Bolis; C Minoia; M Imbriani
Related Documents :
12196905 - Vitamin d deficiency in guinea pigs: exacerbation of bone phenotype during pregnancy an...
25239155 - Cerebrovascular complications of pregnancy and the postpartum period.
19668105 - Nested case-control study of one-carbon metabolites in mid-pregnancy and risks of cleft...
2002665 - Adolescent pregnancy: effects of nutrients on hematocrit and birth weight in orangeburg...
17617195 - Effects of interpregnancy interval and outcome of the preceding pregnancy on pregnancy ...
12515305 - A case of anaemia in a neonatal warthog (phacochoerus aethiopicus) and evaluation of se...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical and experimental obstetrics & gynecology     Volume:  11     ISSN:  0390-6663     ISO Abbreviation:  Clin Exp Obstet Gynecol     Publication Date:  1984  
Date Detail:
Created Date:  1984-07-25     Completed Date:  1984-07-25     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7802110     Medline TA:  Clin Exp Obstet Gynecol     Country:  ITALY    
Other Details:
Languages:  eng     Pagination:  72-5     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Copper / blood*
Time Factors
Zinc / blood*
Reg. No./Substance:
7440-50-8/Copper; 7440-66-6/Zinc

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Theoretical and practical aspects of receptor hormone assay in breast cancer.
Next Document:  Vulvar lesions at risk. Prevention, clinical methodology and therapy.